董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marc Balkin | 男 | Director | 52 | 30.64万美元 | 1.51 | 2026-06-22 |
| Warwick Corden Lloyd | 男 | Chief Financial Officer and Director | 47 | 31.72万美元 | 3.80 | 2026-06-22 |
| Jody Aufrichtig | 男 | Chairman of the Board and Chief Executive Officer | 53 | 43.53万美元 | 5.88 | 2026-06-22 |
| Sashank Pillay | 男 | Director | 49 | 0.38万美元 | 未持股 | 2026-06-22 |
| Graham Patrick | 男 | Director | 45 | 1.50万美元 | 未持股 | 2026-06-22 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Warwick Corden Lloyd | 男 | Chief Financial Officer and Director | 47 | 31.72万美元 | 3.80 | 2026-06-22 |
| Jody Aufrichtig | 男 | Chairman of the Board and Chief Executive Officer | 53 | 43.53万美元 | 5.88 | 2026-06-22 |
董事简历
中英对照 |  中文 |  英文- Marc Balkin
-
Marc Balkin自2021年3月起担任我们的董事兼首席执行官。Balkin先生是Balkin and Co的创始人,这是一家咨询公司,自2015年以来一直为私人股本公司和家族理财室提供合并,收购和投资非洲的建议。惠普的客户包括SAP创始人兼现任董事长Hasso Plattner博士的家族办公室、Omidyar Network(eBay创始人Pierre Omidyar家族办公室的一部分)和兰德商业银行。在创立Balkin and Co之前,Balkin先生是Hasso PlattnerVentures Africa的管理合伙人,这是一家风险基金,其中Plattner博士是关键的有限合伙人。Balkin先生还负责管理Plattner博士家族办公室的私人股本和风险资本资产的新兴市场投资组合。Balkin先生目前是Digame的合伙人,这是一家专注于非洲和中东的成长型基金,其主要投资者是阿布扎比投资顾问公司(“;ADIC”;)。Balkin先生在Direct-to-Consumer Asset Manager10X Investments的董事会中代表Digame,自2004年以来,Balkin先生在一系列风险资本和私募股权基金投资委员会任职并担任主席,作为有限合伙人或投资者的代表。这些公司包括Enablis、第一国民银行Vumela基金、Telkom Future Makers和Alithea IDF。从2000年到2007年,Balkin先生是O2Capital的创始合伙人,这是一家Msele Nedventures Fund的私募股权基金经理。该基金的有限合伙人包括一系列发展融资机构,如Proparco(法国)、DEG(德国)和IDC(南非),该基金主要投资于南非的技术企业。Balkin先生于1995年获得学士学位,并于1997年在约翰内斯堡的威特沃特斯兰德大学获得法学学士学位。
Marc Balkin has served as a director of the Company since January 25, 2024. He served as the Chief Executive Officer and served as a member of the board of directors of NCAC from March 2021 until January 25, 2024. Mr. Balkin is a founder of Balkin and Co, an advisory firm that has advised private equity firms and family offices on mergers, acquisitions and investments in Africa since 2015. Clients have included HP Bet (part of the family office of Dr. Hasso Plattner, a founder and current Chairman of SAP), Omidyar Network (part of the family office of Pierre Omidyar, the founder of eBay) and Rand Merchant Bank. Prior to founding Balkin and Co, Mr. Balkin was the Managing Partner of Hasso Plattner Ventures Africa, a Venture Fund in which Dr. Plattner was the key limited partner. Mr. Balkin also held responsibility for managing the Emerging Market portfolio of private equity and venture capital assets of Dr. Plattner's family office. Mr. Balkin is currently a partner at DiGame, a growth fund focused on Africa and the Middle East in which the key investor is Abu Dhabi Investment Counsel ("ADIC"). Mr. Balkin represents DiGame on the board of direct to consumer asset manager 10X Investments. Since 2004, Mr. Balkin has served on and chaired a range of venture capital and private equity fund investment committees as the representative of the limited partners or investors. These include Enablis, First National Bank Vumela Fund, Telkom Future Makers and Alithea IDF. Between 2000 and 2007, Mr. Balkin was the founding partner of O2 Capital, a private equity fund manager for the Msele Nedventures Fund. The LPs in the fund included a range of development finance institutions such as Proparco (France), DEG (Germany) and IDC (South Africa) and the fund invested primarily in technology businesses in South Africa. Mr. Balkin obtained his BA in 1995 and his LLB in 1997 from University of Witwatersrand in Johannesburg. - Marc Balkin自2021年3月起担任我们的董事兼首席执行官。Balkin先生是Balkin and Co的创始人,这是一家咨询公司,自2015年以来一直为私人股本公司和家族理财室提供合并,收购和投资非洲的建议。惠普的客户包括SAP创始人兼现任董事长Hasso Plattner博士的家族办公室、Omidyar Network(eBay创始人Pierre Omidyar家族办公室的一部分)和兰德商业银行。在创立Balkin and Co之前,Balkin先生是Hasso PlattnerVentures Africa的管理合伙人,这是一家风险基金,其中Plattner博士是关键的有限合伙人。Balkin先生还负责管理Plattner博士家族办公室的私人股本和风险资本资产的新兴市场投资组合。Balkin先生目前是Digame的合伙人,这是一家专注于非洲和中东的成长型基金,其主要投资者是阿布扎比投资顾问公司(“;ADIC”;)。Balkin先生在Direct-to-Consumer Asset Manager10X Investments的董事会中代表Digame,自2004年以来,Balkin先生在一系列风险资本和私募股权基金投资委员会任职并担任主席,作为有限合伙人或投资者的代表。这些公司包括Enablis、第一国民银行Vumela基金、Telkom Future Makers和Alithea IDF。从2000年到2007年,Balkin先生是O2Capital的创始合伙人,这是一家Msele Nedventures Fund的私募股权基金经理。该基金的有限合伙人包括一系列发展融资机构,如Proparco(法国)、DEG(德国)和IDC(南非),该基金主要投资于南非的技术企业。Balkin先生于1995年获得学士学位,并于1997年在约翰内斯堡的威特沃特斯兰德大学获得法学学士学位。
- Marc Balkin has served as a director of the Company since January 25, 2024. He served as the Chief Executive Officer and served as a member of the board of directors of NCAC from March 2021 until January 25, 2024. Mr. Balkin is a founder of Balkin and Co, an advisory firm that has advised private equity firms and family offices on mergers, acquisitions and investments in Africa since 2015. Clients have included HP Bet (part of the family office of Dr. Hasso Plattner, a founder and current Chairman of SAP), Omidyar Network (part of the family office of Pierre Omidyar, the founder of eBay) and Rand Merchant Bank. Prior to founding Balkin and Co, Mr. Balkin was the Managing Partner of Hasso Plattner Ventures Africa, a Venture Fund in which Dr. Plattner was the key limited partner. Mr. Balkin also held responsibility for managing the Emerging Market portfolio of private equity and venture capital assets of Dr. Plattner's family office. Mr. Balkin is currently a partner at DiGame, a growth fund focused on Africa and the Middle East in which the key investor is Abu Dhabi Investment Counsel ("ADIC"). Mr. Balkin represents DiGame on the board of direct to consumer asset manager 10X Investments. Since 2004, Mr. Balkin has served on and chaired a range of venture capital and private equity fund investment committees as the representative of the limited partners or investors. These include Enablis, First National Bank Vumela Fund, Telkom Future Makers and Alithea IDF. Between 2000 and 2007, Mr. Balkin was the founding partner of O2 Capital, a private equity fund manager for the Msele Nedventures Fund. The LPs in the fund included a range of development finance institutions such as Proparco (France), DEG (Germany) and IDC (South Africa) and the fund invested primarily in technology businesses in South Africa. Mr. Balkin obtained his BA in 1995 and his LLB in 1997 from University of Witwatersrand in Johannesburg.
- Warwick Corden Lloyd
-
华威科登劳埃德自2024年1月25日起担任公司首席财务官。Corden Lloyd先生还自2020年5月21日起担任PGI的首席财务官,至2024年1月辞职。Corden Lloyd先生是一名特许会计师和注册项目经理。他在英国和南非的公共会计、咨询和上市金融服务公司拥有超过19年的工作经验。Corden Lloyd先生在国际和新兴市场拥有上市公司财务和监管报告经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2022年3月起担任PsyLabs的全资子公司Psyence UK Group Ltd.的董事会成员。从2020年5月至2021年1月,Corden Lloyd先生曾担任MindHealth Biomed Corp(PGI之前的前身公司)的企业融资顾问和首席财务官。Corden Lloyd先生于2019年5月至2020年5月期间担任Canopy Growth非洲公司(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的运营和财务副总裁。在Canopy Growth期间,他负责监督财务、法律、供应链、人力资源、质量保证和监管、项目管理和国家经理部门。在此之前,他于2015年2月至2019年5月担任南非最大的CTomer零售银行Capitec Bank的财务会计主管,负责管理该银行的财务和监管报告、预算编制和财务会计。在任职于凯德银行之前,他曾任职于南非普华永道国际有限公司、英国以及英国纽约梅隆银行公司。Corden Lloyd先生于2002年获得南非斯泰伦博斯大学会计学学士学位,2003年获得南非纳塔尔大学会计学荣誉学士学位,并于2006年在南非特许会计师协会注册。他还在英格兰和威尔士的特许会计师协会注册。
Warwick Corden Lloyd has served as the Chief Financial Officer of the Company since January 25, 2024. Mr. Corden Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden Lloyd is a Chartered Accountant and Certified Project Manager. He has over 23 years of financial and regulatory experience working in public accounting, consulting and listed financial services companies in the US, UK and South Africa. He has been a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024 and a board member of Novaspore Ltd., a wholly owned subsidiary of PsyLabs, since March 2022. From May 2020 to January 2021, Mr. Corden Lloyd was the Corporate Finance Advisor and Chief Financial Officer of MindHealth Biomed Corp, the predecessor company prior to PGI. Mr. Corden Lloyd was previously the Vice President of Operations and Finance at Canopy Growth Africa, a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED) from May 2019 to May 2020. Whilst at Canopy Growth, he oversaw the Finance, Legal, Supply Chain, Human Resources, Quality Assurance and Regulatory, Project Management and Country Manager divisions. Prior to that he was Head of Financial Accounting at Capitec Bank, South Africa's largest customer retail bank, from February 2015 to May 2019 where he was responsible for managing the financial and regulatory reporting, budgeting and financial accounting for the bank. Before working at Capitec Bank, he worked for PricewaterhouseCoopers International Limited in the US, UK and South Africa and for The Bank of New York Mellon Corporation in the UK. Mr. Corden Lloyd received a Bachelor of Accounting from the University of Stellenbosch, South Africa in 2002, a Bachelor of Accounting Honours from the University of Natal, South Africa in 2003 and registered with the South African Institute of Chartered Accountants in 2006. - 华威科登劳埃德自2024年1月25日起担任公司首席财务官。Corden Lloyd先生还自2020年5月21日起担任PGI的首席财务官,至2024年1月辞职。Corden Lloyd先生是一名特许会计师和注册项目经理。他在英国和南非的公共会计、咨询和上市金融服务公司拥有超过19年的工作经验。Corden Lloyd先生在国际和新兴市场拥有上市公司财务和监管报告经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2022年3月起担任PsyLabs的全资子公司Psyence UK Group Ltd.的董事会成员。从2020年5月至2021年1月,Corden Lloyd先生曾担任MindHealth Biomed Corp(PGI之前的前身公司)的企业融资顾问和首席财务官。Corden Lloyd先生于2019年5月至2020年5月期间担任Canopy Growth非洲公司(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的运营和财务副总裁。在Canopy Growth期间,他负责监督财务、法律、供应链、人力资源、质量保证和监管、项目管理和国家经理部门。在此之前,他于2015年2月至2019年5月担任南非最大的CTomer零售银行Capitec Bank的财务会计主管,负责管理该银行的财务和监管报告、预算编制和财务会计。在任职于凯德银行之前,他曾任职于南非普华永道国际有限公司、英国以及英国纽约梅隆银行公司。Corden Lloyd先生于2002年获得南非斯泰伦博斯大学会计学学士学位,2003年获得南非纳塔尔大学会计学荣誉学士学位,并于2006年在南非特许会计师协会注册。他还在英格兰和威尔士的特许会计师协会注册。
- Warwick Corden Lloyd has served as the Chief Financial Officer of the Company since January 25, 2024. Mr. Corden Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden Lloyd is a Chartered Accountant and Certified Project Manager. He has over 23 years of financial and regulatory experience working in public accounting, consulting and listed financial services companies in the US, UK and South Africa. He has been a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024 and a board member of Novaspore Ltd., a wholly owned subsidiary of PsyLabs, since March 2022. From May 2020 to January 2021, Mr. Corden Lloyd was the Corporate Finance Advisor and Chief Financial Officer of MindHealth Biomed Corp, the predecessor company prior to PGI. Mr. Corden Lloyd was previously the Vice President of Operations and Finance at Canopy Growth Africa, a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED) from May 2019 to May 2020. Whilst at Canopy Growth, he oversaw the Finance, Legal, Supply Chain, Human Resources, Quality Assurance and Regulatory, Project Management and Country Manager divisions. Prior to that he was Head of Financial Accounting at Capitec Bank, South Africa's largest customer retail bank, from February 2015 to May 2019 where he was responsible for managing the financial and regulatory reporting, budgeting and financial accounting for the bank. Before working at Capitec Bank, he worked for PricewaterhouseCoopers International Limited in the US, UK and South Africa and for The Bank of New York Mellon Corporation in the UK. Mr. Corden Lloyd received a Bachelor of Accounting from the University of Stellenbosch, South Africa in 2002, a Bachelor of Accounting Honours from the University of Natal, South Africa in 2003 and registered with the South African Institute of Chartered Accountants in 2006.
- Jody Aufrichtig
-
Jody Aufrichtig自2024年1月25日起担任战略BINCE发展官兼董事会主席,自2020年5月21日起担任PGI董事。自2020年5月21日起,他在PGI担任相同职务。Aufrichtig先生是一位特许会计师和经验丰富的企业家,在新兴市场拥有丰富的经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2021年4月起担任PsyLabs的全资子公司Psyence South Africa(Pty)Ltd.的董事会成员.。Aufrichtig先生是MindHealth Biomed Corp的创始人,他建立了多个获奖的binesses,并在大麻、商业和住宅物业、私募股权、tism、休闲和其他行业创造了可观的股东价值。在创立MindHealth Biomed Corp之前,从2018年5月起,他担任Canopy Growth非洲(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的董事总经理,直到2020年4月他领导了非洲业务的管理层收购。Aufrichtig先生于2017年7月创立了Daddy Cann Lesotho(Pty)Limited,并获得了卫生部(莱索托)颁发的种植、制造、供应、持有、进口、出口和运输大麻的许可证。Daddy Cann Lesotho(Pty)Limited随后于2018年5月被Canopy Growth Corporation收购。2000年,Aufrichtig Co.先生创立了Indigo Properties,这是一家专注于商业和住宅物业、tism和休闲的biness。Aufrichtig先生拥有南非开普敦大学会计学学士学位和荣誉会计学学士学位,并在南非特许会计师协会注册。
Jody Aufrichtig has served as Chairman of the Board of the Company since January 25, 2024 and CEO of the Company since October 15, 2025. He has served as Board Chairman at PGI, and also served as a PGI director, since May 21, 2020. Mr. Aufrichtig is a chartered accountant and experienced entrepreneur with extensive experience in emerging markets. He has served as a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024. Mr. Aufrichtig is the founder of MindHealth Biomed Corp and has built multiple award winning businesses and created substantial shareholder value in cannabis, commercial and residential property, private equity, tourism, leisure and other industries. Prior to founding MindHealth Biomed Corp, he was the Managing Director of Canopy Growth Africa (a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED)) from May 2018 until he led a management buyout of the African operations in April 2020. Mr. Aufrichtig founded Daddy Cann Lesotho (Pty) Limited in July 2017 and was granted a license by the Ministry of Health (Lesotho) to cultivate, manufacture, supply, hold, import, export and transport cannabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co founded Indigo Properties, a business focused on commercial and residential property, tourism and leisure. Mr. Aufrichtig holds a Bachelor of Accounting and a Bachelor of Accounting Honours from the University of Cape Town, South Africa and is registered with the South African Institute of Chartered Accountants. - Jody Aufrichtig自2024年1月25日起担任战略BINCE发展官兼董事会主席,自2020年5月21日起担任PGI董事。自2020年5月21日起,他在PGI担任相同职务。Aufrichtig先生是一位特许会计师和经验丰富的企业家,在新兴市场拥有丰富的经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2021年4月起担任PsyLabs的全资子公司Psyence South Africa(Pty)Ltd.的董事会成员.。Aufrichtig先生是MindHealth Biomed Corp的创始人,他建立了多个获奖的binesses,并在大麻、商业和住宅物业、私募股权、tism、休闲和其他行业创造了可观的股东价值。在创立MindHealth Biomed Corp之前,从2018年5月起,他担任Canopy Growth非洲(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的董事总经理,直到2020年4月他领导了非洲业务的管理层收购。Aufrichtig先生于2017年7月创立了Daddy Cann Lesotho(Pty)Limited,并获得了卫生部(莱索托)颁发的种植、制造、供应、持有、进口、出口和运输大麻的许可证。Daddy Cann Lesotho(Pty)Limited随后于2018年5月被Canopy Growth Corporation收购。2000年,Aufrichtig Co.先生创立了Indigo Properties,这是一家专注于商业和住宅物业、tism和休闲的biness。Aufrichtig先生拥有南非开普敦大学会计学学士学位和荣誉会计学学士学位,并在南非特许会计师协会注册。
- Jody Aufrichtig has served as Chairman of the Board of the Company since January 25, 2024 and CEO of the Company since October 15, 2025. He has served as Board Chairman at PGI, and also served as a PGI director, since May 21, 2020. Mr. Aufrichtig is a chartered accountant and experienced entrepreneur with extensive experience in emerging markets. He has served as a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024. Mr. Aufrichtig is the founder of MindHealth Biomed Corp and has built multiple award winning businesses and created substantial shareholder value in cannabis, commercial and residential property, private equity, tourism, leisure and other industries. Prior to founding MindHealth Biomed Corp, he was the Managing Director of Canopy Growth Africa (a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED)) from May 2018 until he led a management buyout of the African operations in April 2020. Mr. Aufrichtig founded Daddy Cann Lesotho (Pty) Limited in July 2017 and was granted a license by the Ministry of Health (Lesotho) to cultivate, manufacture, supply, hold, import, export and transport cannabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co founded Indigo Properties, a business focused on commercial and residential property, tourism and leisure. Mr. Aufrichtig holds a Bachelor of Accounting and a Bachelor of Accounting Honours from the University of Cape Town, South Africa and is registered with the South African Institute of Chartered Accountants.
- Sashank Pillay
-
Sashank Pillay自2026年2月20日起担任公司董事。继公司对PsyLabs进行大量投资后,鉴于Pillay先生在种植和生产项目执行、设计、施工、运营管理和物流方面的经验,以及对国际受控物质监管框架、质量管理、物流和供应链管理以及海关和进出口便利化的了解,公司任命他为董事会成员。在被任命为PsyLabs之前,Pillay先生曾担任Canopy Growth Africa(Canopy Growth Corporation(纽约证券交易所代码:TERM1/TSX:WEED)的全资子公司)的国家经理(莱索托),负责管理南部非洲政府许可的商业大麻和裸盖菇素种植和生产设施的社区和政府关系联络。在Canopy Growth非洲期间,他还监督了南部非洲的生产、种植、质量保证、监管、项目管理、物流和分销部门。
Sashank Pillay has served as a director of the Company since February 20, 2026. Following the Company's sizable investment in PsyLabs, the Company appointed Mr. Pillay to the Board of Directors given his experience in cultivation and production project execution, design, construction, operations management and logistics, and knowledge of international controlled substance regulatory frameworks, quality management, logistics and supply chain management and customs and import/export facilitation. Prior to his appointment at PsyLabs, Mr Pillay served as the Country Manager (Lesotho) at Canopy Growth Africa, a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED), where he managed community and government relations liaison for governmentally licensed commercial cannabis and psilocybin cultivation and production facilities in Southern Africa. Whilst at Canopy Growth Africa, he also oversaw the Southern African production, cultivation, quality assurance, regulatory, project management, logistics and distribution divisions. - Sashank Pillay自2026年2月20日起担任公司董事。继公司对PsyLabs进行大量投资后,鉴于Pillay先生在种植和生产项目执行、设计、施工、运营管理和物流方面的经验,以及对国际受控物质监管框架、质量管理、物流和供应链管理以及海关和进出口便利化的了解,公司任命他为董事会成员。在被任命为PsyLabs之前,Pillay先生曾担任Canopy Growth Africa(Canopy Growth Corporation(纽约证券交易所代码:TERM1/TSX:WEED)的全资子公司)的国家经理(莱索托),负责管理南部非洲政府许可的商业大麻和裸盖菇素种植和生产设施的社区和政府关系联络。在Canopy Growth非洲期间,他还监督了南部非洲的生产、种植、质量保证、监管、项目管理、物流和分销部门。
- Sashank Pillay has served as a director of the Company since February 20, 2026. Following the Company's sizable investment in PsyLabs, the Company appointed Mr. Pillay to the Board of Directors given his experience in cultivation and production project execution, design, construction, operations management and logistics, and knowledge of international controlled substance regulatory frameworks, quality management, logistics and supply chain management and customs and import/export facilitation. Prior to his appointment at PsyLabs, Mr Pillay served as the Country Manager (Lesotho) at Canopy Growth Africa, a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED), where he managed community and government relations liaison for governmentally licensed commercial cannabis and psilocybin cultivation and production facilities in Southern Africa. Whilst at Canopy Growth Africa, he also oversaw the Southern African production, cultivation, quality assurance, regulatory, project management, logistics and distribution divisions.
- Graham Patrick
-
Graham Patrick自2025年12月1日起担任公司董事。Patrick先生是一名合格的律师、运输商和公证人,在信托监督、良好治理、管理和跨境交易方面拥有丰富的经验。他是Stonehage Fleming的合伙人,Stonehage Fleming是一家全球咨询公司,也是许多世界领先家族和财富创造者的顾问,并领导着他们在毛里求斯的办事处,在那里他担任Stonehage Fleming(Mauritius)Limited及其子公司的董事长和董事。他的职业生涯横跨法律、金融、财富和信托行业。他目前担任多个业务和管辖领域的多家公司的董事会和其他监管任命,包括英属维尔京群岛、毛里求斯、塞舌尔和南非。格雷厄姆拥有商业和法律学位、金融规划研究生文凭,并且是南部非洲信托研究所的成员。
Graham Patrick has served as a director of the Company since December 1, 2025. Mr Patrick is a qualified attorney, conveyancer and notary with extensive experience in fiduciary oversight, good governance, management and cross border transactions. He is a Partner at Stonehage Fleming, a global advisory business and adviser to many of the world's leading families and wealth creators, and heads up their Mauritius office where he acts as chairperson and director for Stonehage Fleming (Mauritius) Limited and its subsidiaries. His career spans legal, financial, wealth and fiduciary industries. He currently holds board and other regulatory appointments for several companies across multiple areas of business and jurisdictions, including the British Virgin Islands, Mauritius, Seychelles and South Africa. Graham holds degrees in commerce and law, a postgraduate diploma in financial planning and is a member of the Fiduciary Institute of Southern Africa. - Graham Patrick自2025年12月1日起担任公司董事。Patrick先生是一名合格的律师、运输商和公证人,在信托监督、良好治理、管理和跨境交易方面拥有丰富的经验。他是Stonehage Fleming的合伙人,Stonehage Fleming是一家全球咨询公司,也是许多世界领先家族和财富创造者的顾问,并领导着他们在毛里求斯的办事处,在那里他担任Stonehage Fleming(Mauritius)Limited及其子公司的董事长和董事。他的职业生涯横跨法律、金融、财富和信托行业。他目前担任多个业务和管辖领域的多家公司的董事会和其他监管任命,包括英属维尔京群岛、毛里求斯、塞舌尔和南非。格雷厄姆拥有商业和法律学位、金融规划研究生文凭,并且是南部非洲信托研究所的成员。
- Graham Patrick has served as a director of the Company since December 1, 2025. Mr Patrick is a qualified attorney, conveyancer and notary with extensive experience in fiduciary oversight, good governance, management and cross border transactions. He is a Partner at Stonehage Fleming, a global advisory business and adviser to many of the world's leading families and wealth creators, and heads up their Mauritius office where he acts as chairperson and director for Stonehage Fleming (Mauritius) Limited and its subsidiaries. His career spans legal, financial, wealth and fiduciary industries. He currently holds board and other regulatory appointments for several companies across multiple areas of business and jurisdictions, including the British Virgin Islands, Mauritius, Seychelles and South Africa. Graham holds degrees in commerce and law, a postgraduate diploma in financial planning and is a member of the Fiduciary Institute of Southern Africa.
高管简历
中英对照 |  中文 |  英文- Warwick Corden Lloyd
华威科登劳埃德自2024年1月25日起担任公司首席财务官。Corden Lloyd先生还自2020年5月21日起担任PGI的首席财务官,至2024年1月辞职。Corden Lloyd先生是一名特许会计师和注册项目经理。他在英国和南非的公共会计、咨询和上市金融服务公司拥有超过19年的工作经验。Corden Lloyd先生在国际和新兴市场拥有上市公司财务和监管报告经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2022年3月起担任PsyLabs的全资子公司Psyence UK Group Ltd.的董事会成员。从2020年5月至2021年1月,Corden Lloyd先生曾担任MindHealth Biomed Corp(PGI之前的前身公司)的企业融资顾问和首席财务官。Corden Lloyd先生于2019年5月至2020年5月期间担任Canopy Growth非洲公司(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的运营和财务副总裁。在Canopy Growth期间,他负责监督财务、法律、供应链、人力资源、质量保证和监管、项目管理和国家经理部门。在此之前,他于2015年2月至2019年5月担任南非最大的CTomer零售银行Capitec Bank的财务会计主管,负责管理该银行的财务和监管报告、预算编制和财务会计。在任职于凯德银行之前,他曾任职于南非普华永道国际有限公司、英国以及英国纽约梅隆银行公司。Corden Lloyd先生于2002年获得南非斯泰伦博斯大学会计学学士学位,2003年获得南非纳塔尔大学会计学荣誉学士学位,并于2006年在南非特许会计师协会注册。他还在英格兰和威尔士的特许会计师协会注册。
Warwick Corden Lloyd has served as the Chief Financial Officer of the Company since January 25, 2024. Mr. Corden Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden Lloyd is a Chartered Accountant and Certified Project Manager. He has over 23 years of financial and regulatory experience working in public accounting, consulting and listed financial services companies in the US, UK and South Africa. He has been a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024 and a board member of Novaspore Ltd., a wholly owned subsidiary of PsyLabs, since March 2022. From May 2020 to January 2021, Mr. Corden Lloyd was the Corporate Finance Advisor and Chief Financial Officer of MindHealth Biomed Corp, the predecessor company prior to PGI. Mr. Corden Lloyd was previously the Vice President of Operations and Finance at Canopy Growth Africa, a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED) from May 2019 to May 2020. Whilst at Canopy Growth, he oversaw the Finance, Legal, Supply Chain, Human Resources, Quality Assurance and Regulatory, Project Management and Country Manager divisions. Prior to that he was Head of Financial Accounting at Capitec Bank, South Africa's largest customer retail bank, from February 2015 to May 2019 where he was responsible for managing the financial and regulatory reporting, budgeting and financial accounting for the bank. Before working at Capitec Bank, he worked for PricewaterhouseCoopers International Limited in the US, UK and South Africa and for The Bank of New York Mellon Corporation in the UK. Mr. Corden Lloyd received a Bachelor of Accounting from the University of Stellenbosch, South Africa in 2002, a Bachelor of Accounting Honours from the University of Natal, South Africa in 2003 and registered with the South African Institute of Chartered Accountants in 2006.- 华威科登劳埃德自2024年1月25日起担任公司首席财务官。Corden Lloyd先生还自2020年5月21日起担任PGI的首席财务官,至2024年1月辞职。Corden Lloyd先生是一名特许会计师和注册项目经理。他在英国和南非的公共会计、咨询和上市金融服务公司拥有超过19年的工作经验。Corden Lloyd先生在国际和新兴市场拥有上市公司财务和监管报告经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2022年3月起担任PsyLabs的全资子公司Psyence UK Group Ltd.的董事会成员。从2020年5月至2021年1月,Corden Lloyd先生曾担任MindHealth Biomed Corp(PGI之前的前身公司)的企业融资顾问和首席财务官。Corden Lloyd先生于2019年5月至2020年5月期间担任Canopy Growth非洲公司(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的运营和财务副总裁。在Canopy Growth期间,他负责监督财务、法律、供应链、人力资源、质量保证和监管、项目管理和国家经理部门。在此之前,他于2015年2月至2019年5月担任南非最大的CTomer零售银行Capitec Bank的财务会计主管,负责管理该银行的财务和监管报告、预算编制和财务会计。在任职于凯德银行之前,他曾任职于南非普华永道国际有限公司、英国以及英国纽约梅隆银行公司。Corden Lloyd先生于2002年获得南非斯泰伦博斯大学会计学学士学位,2003年获得南非纳塔尔大学会计学荣誉学士学位,并于2006年在南非特许会计师协会注册。他还在英格兰和威尔士的特许会计师协会注册。
- Warwick Corden Lloyd has served as the Chief Financial Officer of the Company since January 25, 2024. Mr. Corden Lloyd has also served as Chief Financial Officer of PGI from May 21, 2020 until his resignation in January 2024. Mr. Corden Lloyd is a Chartered Accountant and Certified Project Manager. He has over 23 years of financial and regulatory experience working in public accounting, consulting and listed financial services companies in the US, UK and South Africa. He has been a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024 and a board member of Novaspore Ltd., a wholly owned subsidiary of PsyLabs, since March 2022. From May 2020 to January 2021, Mr. Corden Lloyd was the Corporate Finance Advisor and Chief Financial Officer of MindHealth Biomed Corp, the predecessor company prior to PGI. Mr. Corden Lloyd was previously the Vice President of Operations and Finance at Canopy Growth Africa, a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED) from May 2019 to May 2020. Whilst at Canopy Growth, he oversaw the Finance, Legal, Supply Chain, Human Resources, Quality Assurance and Regulatory, Project Management and Country Manager divisions. Prior to that he was Head of Financial Accounting at Capitec Bank, South Africa's largest customer retail bank, from February 2015 to May 2019 where he was responsible for managing the financial and regulatory reporting, budgeting and financial accounting for the bank. Before working at Capitec Bank, he worked for PricewaterhouseCoopers International Limited in the US, UK and South Africa and for The Bank of New York Mellon Corporation in the UK. Mr. Corden Lloyd received a Bachelor of Accounting from the University of Stellenbosch, South Africa in 2002, a Bachelor of Accounting Honours from the University of Natal, South Africa in 2003 and registered with the South African Institute of Chartered Accountants in 2006.
- Jody Aufrichtig
Jody Aufrichtig自2024年1月25日起担任战略BINCE发展官兼董事会主席,自2020年5月21日起担任PGI董事。自2020年5月21日起,他在PGI担任相同职务。Aufrichtig先生是一位特许会计师和经验丰富的企业家,在新兴市场拥有丰富的经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2021年4月起担任PsyLabs的全资子公司Psyence South Africa(Pty)Ltd.的董事会成员.。Aufrichtig先生是MindHealth Biomed Corp的创始人,他建立了多个获奖的binesses,并在大麻、商业和住宅物业、私募股权、tism、休闲和其他行业创造了可观的股东价值。在创立MindHealth Biomed Corp之前,从2018年5月起,他担任Canopy Growth非洲(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的董事总经理,直到2020年4月他领导了非洲业务的管理层收购。Aufrichtig先生于2017年7月创立了Daddy Cann Lesotho(Pty)Limited,并获得了卫生部(莱索托)颁发的种植、制造、供应、持有、进口、出口和运输大麻的许可证。Daddy Cann Lesotho(Pty)Limited随后于2018年5月被Canopy Growth Corporation收购。2000年,Aufrichtig Co.先生创立了Indigo Properties,这是一家专注于商业和住宅物业、tism和休闲的biness。Aufrichtig先生拥有南非开普敦大学会计学学士学位和荣誉会计学学士学位,并在南非特许会计师协会注册。
Jody Aufrichtig has served as Chairman of the Board of the Company since January 25, 2024 and CEO of the Company since October 15, 2025. He has served as Board Chairman at PGI, and also served as a PGI director, since May 21, 2020. Mr. Aufrichtig is a chartered accountant and experienced entrepreneur with extensive experience in emerging markets. He has served as a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024. Mr. Aufrichtig is the founder of MindHealth Biomed Corp and has built multiple award winning businesses and created substantial shareholder value in cannabis, commercial and residential property, private equity, tourism, leisure and other industries. Prior to founding MindHealth Biomed Corp, he was the Managing Director of Canopy Growth Africa (a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED)) from May 2018 until he led a management buyout of the African operations in April 2020. Mr. Aufrichtig founded Daddy Cann Lesotho (Pty) Limited in July 2017 and was granted a license by the Ministry of Health (Lesotho) to cultivate, manufacture, supply, hold, import, export and transport cannabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co founded Indigo Properties, a business focused on commercial and residential property, tourism and leisure. Mr. Aufrichtig holds a Bachelor of Accounting and a Bachelor of Accounting Honours from the University of Cape Town, South Africa and is registered with the South African Institute of Chartered Accountants.- Jody Aufrichtig自2024年1月25日起担任战略BINCE发展官兼董事会主席,自2020年5月21日起担任PGI董事。自2020年5月21日起,他在PGI担任相同职务。Aufrichtig先生是一位特许会计师和经验丰富的企业家,在新兴市场拥有丰富的经验。他自2024年4月起担任PsyLabs的顾问,PsyLabs是一家私人控股公司,专门生产用于研究、临床试验和药物开发的迷幻活性药物成分和提取物,是公司的关联公司,自2021年4月起担任PsyLabs的全资子公司Psyence South Africa(Pty)Ltd.的董事会成员.。Aufrichtig先生是MindHealth Biomed Corp的创始人,他建立了多个获奖的binesses,并在大麻、商业和住宅物业、私募股权、tism、休闲和其他行业创造了可观的股东价值。在创立MindHealth Biomed Corp之前,从2018年5月起,他担任Canopy Growth非洲(Canopy Growth Corporation(纽约证券交易所代码:CGC/TSX:ED)的全资子公司)的董事总经理,直到2020年4月他领导了非洲业务的管理层收购。Aufrichtig先生于2017年7月创立了Daddy Cann Lesotho(Pty)Limited,并获得了卫生部(莱索托)颁发的种植、制造、供应、持有、进口、出口和运输大麻的许可证。Daddy Cann Lesotho(Pty)Limited随后于2018年5月被Canopy Growth Corporation收购。2000年,Aufrichtig Co.先生创立了Indigo Properties,这是一家专注于商业和住宅物业、tism和休闲的biness。Aufrichtig先生拥有南非开普敦大学会计学学士学位和荣誉会计学学士学位,并在南非特许会计师协会注册。
- Jody Aufrichtig has served as Chairman of the Board of the Company since January 25, 2024 and CEO of the Company since October 15, 2025. He has served as Board Chairman at PGI, and also served as a PGI director, since May 21, 2020. Mr. Aufrichtig is a chartered accountant and experienced entrepreneur with extensive experience in emerging markets. He has served as a consultant of PsyLabs, a privately held company specializing in the production of psychedelic active pharmaceutical ingredients and extracts for research, clinical trials, and drug development and an affiliate of the Company, since April 2024. Mr. Aufrichtig is the founder of MindHealth Biomed Corp and has built multiple award winning businesses and created substantial shareholder value in cannabis, commercial and residential property, private equity, tourism, leisure and other industries. Prior to founding MindHealth Biomed Corp, he was the Managing Director of Canopy Growth Africa (a wholly owned subsidiary of Canopy Growth Corporation (NYSE: CGC / TSX: WEED)) from May 2018 until he led a management buyout of the African operations in April 2020. Mr. Aufrichtig founded Daddy Cann Lesotho (Pty) Limited in July 2017 and was granted a license by the Ministry of Health (Lesotho) to cultivate, manufacture, supply, hold, import, export and transport cannabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co founded Indigo Properties, a business focused on commercial and residential property, tourism and leisure. Mr. Aufrichtig holds a Bachelor of Accounting and a Bachelor of Accounting Honours from the University of Cape Town, South Africa and is registered with the South African Institute of Chartered Accountants.